Executive summary Alzheimer's disease (AD) is the leading cause of dementia, and
because the primary risk factor for AD is old age, the prevalence of the disease is increasing …

While it is generally understood that Alzheimer's disease (AD) and related dementias
(ADRD) is one of the costliest diseases to society, there is widespread concern that …

Introduction The socioeconomic costs of Alzheimer's disease (AD) in China and its impact
on global economic burden remain uncertain. Methods We collected data from 3098 …

The National Institute on Aging and the Alzheimer's Association charged a workgroup with
the task of develo** criteria for the symptomatic predementia phase of Alzheimer's …

BACKGROUND: The spectrum of disorders of the brain is large, covering hundreds of
disorders that are listed in either the mental or neurological disorder chapters of the …

Importance Several anti–amyloid monoclonal antibodies have been developed for slowing
the progression of Alzheimer disease (AD). Among the furthest developed are aducanumab …

Abstract Background and Objective The prevalence of dementia is increasing, while new
opportunities for diagnosing, treating and possibly preventing Alzheimer's disease and other …

Objectives Alzheimer's disease (AD) has become one of the most prevalent
neurodegenerative disorders among the elderly. The global cost of dementia is expected to …

Background: Alzheimer's disease (AD) weighs heavily on health expenditure and is strongly
associated with increasing age. Due to population aging, increasing global prevalence of …

Objective To summarise existing systematic reviews that assess the effects of non-
pharmacological, pharmacological and alternative therapies on activities of daily living …